These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 29266842)

  • 1. Development and Validation of Mass Spectrometry-Based Targeted Analysis for Amyloid Proteins.
    Park J; Lee GY; Choi JO; Jeon ES; Kim K; Kim JS; Lee SY
    Proteomics Clin Appl; 2018 May; 12(3):e1700106. PubMed ID: 29266842
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Precise diagnosis and typing of early-stage renal immunoglobulin-derived amyloidosis by label-free quantification of parallel reaction monitoring-based targeted proteomics.
    Li Y; Zhang Y; Zhou X; Xue X; Wang M; Kang D; Zhou Y; Hu R; Quan S; Xing G; Yang J
    BMC Nephrol; 2023 Mar; 24(1):50. PubMed ID: 36894904
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Classification of amyloidosis by laser micro-dissection and mass spectrometry based proteomic analysis].
    Shen K; Sun W; Sun J; Sun W; Zhong D; Cao X; Zhou D; Li J
    Zhonghua Xue Ye Xue Za Zhi; 2015 Feb; 36(2):99-102. PubMed ID: 25778882
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mass spectrometry-based proteomic diagnosis of renal immunoglobulin heavy chain amyloidosis.
    Sethi S; Theis JD; Leung N; Dispenzieri A; Nasr SH; Fidler ME; Cornell LD; Gamez JD; Vrana JA; Dogan A
    Clin J Am Soc Nephrol; 2010 Dec; 5(12):2180-7. PubMed ID: 20876678
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Classification of Amyloidosis by Model-Assisted Mass Spectrometry-Based Proteomics.
    Palstrøm NB; Rojek AM; Møller HEH; Hansen CT; Matthiesen R; Rasmussen LM; Abildgaard N; Beck HC
    Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008745
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical proteomics for diagnosis and typing of systemic amyloidoses.
    Brambilla F; Lavatelli F; Merlini G; Mauri P
    Proteomics Clin Appl; 2013 Jan; 7(1-2):136-43. PubMed ID: 23184874
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sensitive, Simple, and Robust Nano-Liquid Chromatography-Mass Spectrometry Method for Amyloid Protein Subtyping.
    Payto D; Heideloff C; Wang S
    Methods Mol Biol; 2016; 1378():55-60. PubMed ID: 26602117
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Classification of amyloidosis by laser microdissection and mass spectrometry-based proteomic analysis in clinical biopsy specimens.
    Vrana JA; Gamez JD; Madden BJ; Theis JD; Bergen HR; Dogan A
    Blood; 2009 Dec; 114(24):4957-9. PubMed ID: 19797517
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [New advances in the subtyping of systemic amyloidosis].
    Sun WY; Li J
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Feb; 22(1):259-62. PubMed ID: 24598691
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A stepwise data interpretation process for renal amyloidosis typing by LMD-MS.
    Ke M; Li X; Wang L; Yue S; Zhao B
    BMC Nephrol; 2022 Apr; 23(1):144. PubMed ID: 35418036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Implementation and evaluation of amyloidosis subtyping by laser-capture microdissection and tandem mass spectrometry.
    Mollee P; Boros S; Loo D; Ruelcke JE; Lakis VA; Cao KL; Renaut P; Hill MM
    Clin Proteomics; 2016; 13():30. PubMed ID: 27795698
    [TBL] [Abstract][Full Text] [Related]  

  • 12. How I treat amyloidosis: the importance of accurate diagnosis and amyloid typing.
    Leung N; Nasr SH; Sethi S
    Blood; 2012 Oct; 120(16):3206-13. PubMed ID: 22948045
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sensitive and rapid assessment of amyloid by oligothiophene fluorescence in subcutaneous fat tissue.
    Sjölander D; Bijzet J; Hazenberg BP; Nilsson KP; Hammarström P
    Amyloid; 2015 Mar; 22(1):19-25. PubMed ID: 25847117
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proteomic typing of amyloid deposits in systemic amyloidoses.
    Lavatelli F; Vrana JA
    Amyloid; 2011 Dec; 18(4):177-82. PubMed ID: 22080761
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Proteomics, a new tool for an accurate typing of amyloidosis].
    Colombat M; Holifanjaniaina S; Onifarasoaniaina S; Valleix S; Maisonneuve H; Kahn JE;
    Rev Med Interne; 2015 May; 36(5):346-51. PubMed ID: 25544147
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proteomics in molecular diagnosis: typing of amyloidosis.
    Loo D; Mollee PN; Renaut P; Hill MM
    J Biomed Biotechnol; 2011; 2011():754109. PubMed ID: 22131817
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Amyloid typing from formalin-fixed paraffin-embedded tissues using LMD-LC-MS/MS system].
    Tasaki M; Obayashi K; Ueda M; Ando Y
    Rinsho Byori; 2014 Mar; 62(3):291-6. PubMed ID: 24800507
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyphenated Mass Spectrometry Techniques in the Diagnosis of Amyloidosis.
    Spodzieja M; Rodziewicz-Motowidło S; Szymanska A
    Curr Med Chem; 2019; 26(1):104-120. PubMed ID: 28971756
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Leukocyte chemotactic factor 2 amyloidosis cannot be reliably diagnosed by immunohistochemical staining.
    Paueksakon P; Fogo AB; Sethi S
    Hum Pathol; 2014 Jul; 45(7):1445-50. PubMed ID: 24792621
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mass Spectrometry Amyloid Typing Is Reproducible across Multiple Organ Sites.
    Holub D; Flodrova P; Pika T; Flodr P; Hajduch M; Dzubak P
    Biomed Res Int; 2019; 2019():3689091. PubMed ID: 30834260
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.